CTA
AMGN icon

Chesley Taft & Associates’s Amgen AMGN Stock Holding History

Chesley Taft & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84M Sell
18,897
-1,191
-6% -$408K 0.27% 80
2026
Q1 		$7.07M Sell
20,088
-74
-0.4% -$26.4K 0.3% 77
2025
Q4 		$6.6M Buy
20,162
+2,565
+15% +$814K 0.26% 77
2025
Q3 		$4.97M Sell
17,597
-2,373
-12% -$688K 0.21% 91
2025
Q2 		$5.58M Buy
19,970
+163
+0.8% +$46.2K 0.25% 86
2025
Q1 		$6.17M Buy
19,807
+502
+3% +$148K 0.3% 78
2024
Q4 		$5.03M Buy
19,305
+383
+2% +$114K 0.23% 85
2024
Q3 		$6.1M Buy
18,922
+174
+0.9% +$56.9K 0.29% 74
2024
Q2 		$5.86M Sell
18,748
-217
-1% -$63.8K 0.29% 71
2024
Q1 		$5.39M Buy
18,965
+586
+3% +$171K 0.28% 77
2023
Q4 		$5.29M Buy
18,379
+1,399
+8% +$381K 0.3% 72
2023
Q3 		$4.56M Buy
16,980
+3,060
+22% +$764K 0.3% 76
2023
Q2 		$3.09M Hold
13,920
– – 0.19% 105
2023
Q1 		$3.37M Sell
13,920
-45
-0.3% -$11K 0.22% 99
2022
Q4 		$3.67M Sell
13,965
-30
-0.2% -$8.04K 0.25% 89
2022
Q3 		$3.15M Sell
13,995
-130
-0.9% -$31.5K 0.23% 96
2022
Q2 		$3.44M Sell
14,125
-20
-0.1% -$4.9K 0.23% 96
2022
Q1 		$3.54M Buy
14,145
+75
+0.5% +$17.2K 0.21% 104
2021
Q4 		$3.17M Buy
14,070
+1,075
+8% +$227K 0.16% 116
2021
Q3 		$2.76M Sell
12,995
-5
-0% -$1.15K 0.16% 120
2021
Q2 		$3.17M Sell
13,000
-45,729
-78% -$11.2M 0.18% 109
2021
Q1 		$14.8M Buy
58,729
+75
+0.1% +$17.9K 0.88% 30
2020
Q4 		$13.5M Buy
58,654
+45,156
+335% +$10.4M 0.86% 31
2020
Q3 		$3.43M Sell
13,498
-140
-1% -$34.7K 0.24% 87
2020
Q2 		$3.22M Sell
13,638
-255
-2% -$58.2K 0.24% 89
2020
Q1 		$2.82M Buy
13,893
+2,290
+20% +$500K 0.26% 84
2019
Q4 		$2.8M Sell
11,603
-20
-0.2% -$4.41K 0.2% 95
2019
Q3 		$2.25M Sell
11,623
-4,024
-26% -$772K 0.17% 107
2019
Q2 		$2.88M Buy
15,647
+345
+2% +$61.8K 0.22% 90
2019
Q1 		$2.91M Sell
15,302
-7,202
-32% -$1.38M 0.24% 85
2018
Q4 		$4.38M Sell
22,504
-510
-2% -$99.5K 0.42% 65
2018
Q3 		$4.77M Buy
23,014
+975
+4% +$192K 0.38% 70
2018
Q2 		$4.07M Sell
22,039
-591
-3% -$105K 0.35% 78
2018
Q1 		$3.86M Buy
22,630
+1,640
+8% +$301K 0.34% 75
2017
Q4 		$3.65M Buy
20,990
+11,603
+124% +$2.05M 0.31% 84
2017
Q3 		$1.75M Buy
9,387
+1,020
+12% +$181K 0.15% 129
2017
Q2 		$1.44M Buy
8,367
+350
+4% +$56.9K 0.13% 138
2017
Q1 		$1.31M Sell
8,017
-51,070
-86% -$8.49M 0.12% 141
2016
Q4 		$8.64M Buy
59,087
+52,370
+780% +$7.88M 0.85% 38
2016
Q3 		$1.12M Sell
6,717
-52,360
-89% -$8.85M 0.11% 145
2016
Q2 		$8.99M Buy
59,077
+315
+0.5% +$49K 0.92% 38
2016
Q1 		$8.81M Buy
58,762
+865
+1% +$129K 0.93% 39
2015
Q4 		$9.4M Sell
57,897
-8,425
-13% -$1.32M 0.99% 35
2015
Q3 		$9.17M Sell
66,322
-1,100
-2% -$173K 1% 38
2015
Q2 		$10.4M Buy
67,422
+675
+1% +$108K 1.06% 35
2015
Q1 		$10.7M Buy
66,747
+2,805
+4% +$442K 1.09% 33
2014
Q4 		$10.2M Buy
63,942
+3,295
+5% +$513K 1.03% 39
2014
Q3 		$8.52M Buy
60,647
+53,375
+734% +$6.97M 0.89% 44
2014
Q2 		$861K Hold
7,272
– – 0.09% 152
2014
Q1 		$897K Hold
7,272
– – 0.1% 147
2013
Q4 		$830K Buy
7,272
+7
+0.1% +$796 0.08% 172
2013
Q3 		$813K Buy
7,265
+100
+1% +$10.8K 0.09% 167
2013
Q2 		$707K Buy
+7,165
New +$744K 0.08% 174

Other funds holding AMGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Chesley Taft & Associates's AMGN Position: Q2 2026 in Review

Chesley Taft & Associates reduced its Amgen (AMGN) stake by 5.9% in Q2 2026, selling an estimated $408K and leaving 18,897 shares worth $6.84M. The position accounts for 0.27% of the portfolio, ranked #80.

Chesley Taft & Associates first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.8M in Q1 2021. 748 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Chesley Taft & Associates held 18,897 shares of Amgen worth $6.84M as of Q2 2026.
  • Chesley Taft & Associates sold 1,191 Amgen shares in Q2 2026, an estimated $408K.
  • Amgen made up 0.27% of Chesley Taft & Associates's portfolio in Q2 2026, its #80 holding.
  • Chesley Taft & Associates first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Chesley Taft & Associates's Amgen position peaked at $14.8M in Q1 2021.
  • 748 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.